
News of Guerbet
Guerbet and Bracco Enter Into Global Collaboration for Next-Generation MRI Contrast Agent Gadopiclenol
15 Dec 2021
Guerbet (Paris, France) and Bracco Imaging S.p.A. (Milan, Italy) have signed a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent, that will result in the companies commercializing the product independently under different brand names. The companies will also collaborate on manufacturing, as well as research and development for future indications.
Read More
Guerbet Partners with Imalogix on Dose Optimization with AI
20 Aug 2018
Guerbet LLC USA, the US affiliate of the the Guerbet Group, which specializes in contrast product and solutions for medical imaging, has entered into a commercial partnership with Imalogix, a provider of artificial intelligence (AI) process and workflow solutions.
Read More
Guerbet and IBM Watson Health to Jointly Develop AI Software
16 Jul 2018
Guerbet, which specializes in contrast agents and solutions for diagnostic and interventional medical imaging, has signed an agreement with IBM Watson Health to jointly develop an artificial intelligence (AI) software solution for supporting liver cancer diagnostics and care.
Read More
Medical Imaging Specialist Guerbet Celebrates Its 90th Year
15 Nov 2016
Guerbet, a specialist in contrast agents and solutions for medical imaging, will be celebrating its 90th year on November 15, 2016. The Group is one of the leading players in medical imaging worldwide and offers a full range of medical solutions and services.
Read More